Trial Profile
Effect of pioglitazone in combination with glimepiride therapy on various parameters of insulin resistance including lipoprotein subclass levels in patients with type 2 diabetes.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Glimepiride; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 11 Sep 2009 New trial record